Navigation Links
No Benefit to Lowering Blood Pressure in Acute Stroke: Study
Date:2/11/2011

By Steven Reinberg
HealthDay Reporter

FRIDAY, Feb. 11 (HealthDay News) -- Giving medication to lower blood pressure in hypertensive stroke patients appears to have no benefit and might even be harmful, says a new study that seems to confirm current treatment guidelines.

"Clinicians should not be prescribing blood-pressure-lowering drugs within the first week of acute stroke in routine practice, but researchers should continue to evaluate the safety and effectiveness of other interventions for blood pressure in acute stroke," said Dr. Graeme J. Hankey, head of the Stroke Unit at Royal Perth Hospital in Australia, who is familiar with the study.

Researchers looked at the effect of the blood pressure-lowering drug candesartan on about 1,000 acute stroke patients. Their findings are published online Feb. 11 in The Lancet to coincide with presentation of the study at the International Stroke Conference in Los Angeles.

When added to the results of 10 previous trials, this study indicates that lowering blood pressure in the first week after acute stroke has no overall benefit on subsequent outcome, said Hankey, author of an accompanying journal editorial.

Doctors have been unsure how to treat high blood pressure in acute stroke patients, and current guidelines recommend leaving it alone.

For the study, a multicenter team led by Dr. Eivind Berge from Oslo University Hospital Ulleval in Norway randomly assigned 2,029 acute stroke patients to take candesartan (Atacand) or a placebo. Candesartan belongs to a family of drugs called angiotensin-receptor blockers.

Over a week, the drug significantly lowered the blood pressure of patients receiving it. However, over six months no difference emerged between the two groups in the risk of death, heart attack or stroke, the researchers found.

Moreover, patients taking the drug tended to have poorer outcomes, compared with patients receiving placebo, although this finding was not statistically significant, Berge's group says.

Among those taking candesartan, nine had symptoms associated with low blood pressure, compared with five patients taking placebo. In addition, 18 patients taking candesartan suffered kidney failure, compared with 13 patients receiving placebo, the researchers note.

Berge's team reviewed other studies, which also showed that lowering blood pressure in acute stroke patients had no benefit.

"Other trials are ongoing, but until these trials have been completed we see no place for routine blood pressure-lowering treatment in the acute phase of stroke," the researchers conclude.

Commenting on the study, Dr. Larry B. Goldstein, professor of neurology and director of the Duke Stroke Center at Duke University Medical Center , said that "the optimal treatment of elevated blood pressure in the setting of acute ischemic stroke has been uncertain because of a lack of adequate controlled trials."

Current guidelines recommend that blood pressure should generally not be lowered during the acute phase of ischemic stroke, because doing so might compromise circulation to the damaged brain. "This study supports these existing recommendations," he said.

More information

For more information on stroke, visit the U.S. National Library of Medicine.

SOURCES: Larry B. Goldstein, M.D., professor, neurology, and director, Duke Stroke Center, Duke University Medical Center, Durham, N.C.; Graeme J. Hankey, M.D., consultant neurologist and head, Stroke Unit, Royal Perth Hospital and University of Western Australia, Perth; Feb. 11, 2011, The Lancet, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Children With Cerebral Palsy Benefitting From New Physical Therapy Regimen
2. Kaiser Permanente Approves $170 Million in Community Benefit Grants in 2009
3. Survival benefit with high-intensity end-of-life approaches
4. Alzheimers Foundation of America Applauds Social Security for Speeding Disability Benefits for Early-Onset Alzheimers Disease
5. Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates Fight Against Breast Cancer
6. News brief: Benefit of HPV Vaccination, Frequent Screening for Women over 41 is Likely to be Low
7. 1Dental.com Enhances Dental Plan Benefits With New Fee Schedule
8. AMERICAN IDOL to Benefit the UN Foundation Fund for Haiti Thursday, February 25, on FOX
9. Freedom Healthnet Affirms Affordable Private Health Insurance Benefits
10. Statins May Benefit Prostate Cancer Patients
11. PCMA: Proposed Overhaul of FEHBP Pharmacy Benefit Would Undermine Cost-Saving Tools, Reduce Choices for 8 Million Americans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
No Benefit to Lowering Blood Pressure in Acute Stroke: Study 
(Date:7/21/2017)... ... 21, 2017 , ... In the first prospective ACL reconstruction ... Outcome Network (MOON) demonstrated that patients could perform sports-related functions and maintain a ... over time. The study, presented today at the American Orthopaedic Society for ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... rates are on the rise, say researchers presenting their work at the ... Canada. , “The combination of evaluating the patterns of change in concussion symptom ...
(Date:7/20/2017)... Richmond, Va. (PRWEB) , ... July 20, 2017 , ... ... Daniel McCarter, MD, has joined JenCare Senior Medical Center as Richmond Chief ... of Virginia School of Medicine, and Associate Chief Medical Officer of Ambulatory Services for ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... and application performance monitoring (APM) solutions, has expanded its footprint inside the ... According to Peter Ohrenberger, sales director at Nastel, “We’ve replaced an existing ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... For individuals ... utmost importance. The adjustable beds used in such facilities are specially designed to accommodate ... adequate arm support. , An inventor from Rochester, Ind., has invented the patent-pending ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... 13, 2017 It should come as no surprise ... is in the midst of a crippling opioid epidemic. According ... the number of overdose deaths from opiate-based medications has quadrupled, ... a million dead from 2001 to 2015". During this time, ... has similarly quadrupled, drawing a compelling link between prescription and ...
(Date:7/13/2017)... 2017 RK Logistics Group, Inc. was awarded ... its Fremont, CA headquarters facility where ... and San Jose for hi-tech, pharmaceutical ... , with its Fremont Innovation District, is excited to ... powerful resource to the hundreds of biotech, pharma and biomed ...
(Date:7/12/2017)... -- CarpalAID is a revolutionary new product that relieves painful carpal ... tunnel syndrome affects more than 8 million people a year. Women ... The common methods of treating CTS are painful surgery, the use ... gloves. ... CarpalAID is a clear patch worn on the palm of the ...
Breaking Medicine Technology: